- Relay Therapeutics (NASDAQ:RLAY): Q3 GAAP EPS of -$3.00.
- Cash, cash equivalents and investments of $713M.
- Press Release
Relay Therapeutics reports Q3 results
Recommended For You
More Trending News
About RLAY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| RLAY | - | - |
| Relay Therapeutics, Inc. | ||